Gene Discovery

New Findings Help to Understand the Von Hippel-Lindau Tumor Suppressor Gene

Published in Cancer Weekly, September 25th, 1995

A potential breakthrough for cancer prevention and treatment has some Oklahoma doctors combining efforts with physicians nationwide in an effort to develop new ways to combat the disease.

Oklahoma Medical Research Foundation (OMRF) scientists Drs. Joan and Ronald Conaway have found a key element in understanding the von Hippel-Lindau tumor suppressor gene that predisposes people to cancer.

"We hope it will lead to the development of new drugs to treat cancer," Conaway said.

The September 18, 1995, issue of Science magazine includes two articles detailing the Conaway's contribution to the project along with collaborators from the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1995-09-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry